Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.1K
The pathophysiology of pneumonia involves the following steps:
4.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between the diagnostic probability of chronic kidney disease calculated using artificial intelligence-enhanced electrocardiography and the incidence of cardiovascular events.

International journal of cardiology·2026
Same author

Prediction of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography　- Does Left Atrial Size Matter?

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa.

Nature communications·2026
Same author

Comparison of remimazolam and sevoflurane on requirement of inotropes and vasopressors in cardiopulmonary bypass surgery: a propensity-score-matched retrospective cohort study.

Minerva anestesiologica·2026
Same author

Overlapping pathologies: Adrenal insufficiency presenting as refractory acute heart failure.

Journal of cardiology cases·2026
Same author

Assessment of Anesthetic Depth Through EEG Mode Decomposition Using Singular Spectrum Analysis.

Sensors (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

[Interstitial Pneumonia and Emphysema].

Teiji Sawa, Yuko Kato, Sachiyo Ishii

    Masui. the Japanese Journal of Anesthesiology
    |October 16, 2015
    PubMed
    Summary

    Anesthesiologists assess anesthesia risks for patients with interstitial pneumonia (IP) and chronic obstructive pulmonary disease (COPD). Careful evaluation of disease severity, prognosis, and patient factors is crucial for safe anesthetic management, especially in moderate disease stages.

    Area of Science:

    • Anesthesiology
    • Pulmonology
    • Critical Care Medicine

    Background:

    • Interstitial pneumonia (IP) causes restrictive lung dysfunction, while chronic obstructive pulmonary disease (COPD) causes obstructive lung dysfunction.
    • Anesthesiologists frequently evaluate patients with IP and COPD in preoperative anesthesia clinics.
    • Respiratory function tests define IP by decreased % vital capacity (<80%) and COPD by decreased % forced expiratory volume in 1 second (FEV1.0) (<70%).

    Purpose of the Study:

    • To outline key factors for assessing anesthesia management in patients with IP and COPD.
    • To guide anesthesiologists in risk stratification and decision-making for surgical patients with pulmonary dysfunction.

    Main Methods:

    • Assessment of disease severity impacting anesthesia safety.

    More Related Videos

    Experimental Model to Evaluate Resolution of Pneumonia
    09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    2.0K
    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.3K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    21.1K
    Experimental Model to Evaluate Resolution of Pneumonia
    09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    2.0K
    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.3K
  • Prognostic evaluation, including risk of postoperative acute exacerbation.
  • Consideration of patient-specific factors: age, autonomy, comorbidities.
  • Evaluation of surgery-related factors and anesthesia techniques.

    • Main Results:

    • Anesthesia management is relatively safe for patients in disease stages I or II.
    • Patients in disease stage IV generally lack surgical indications, except for life-saving emergencies.
    • Anesthesiologists must critically assess patients in disease stage III based on multiple factors for safe anesthesia.

    Conclusions:

    • Comprehensive assessment of disease severity, prognosis, and patient/surgery-related factors is essential for safe anesthesia in IP and COPD patients.
    • Risk stratification guides anesthetic decisions, particularly for patients with moderate (stage III) pulmonary disease.
    • Tailored anesthesia management plans are crucial for optimizing outcomes in patients with restrictive or obstructive pulmonary dysfunction.